Literature DB >> 16700697

Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis.

A Sensini1.   

Abstract

Because of its life cycle, the recovery of Toxoplasma gondii from biological samples is often impracticable. Consequently, a serological diagnosis represents the first and the most widely used approach to defining the stage of infection. The detection of IgG, IgM, IgA, IgE and IgG avidity by different methods offers this opportunity. However, the results may be affected by difficulties in interpretation, as the same antibody pattern may have a different valency, contingent upon subjects and clinical settings, e.g., pregnant women vs. neonates, and treated vs. untreated patients. This review describes the various factors that should be taken into account when performing serological tests for T. gondii, as well as the pitfalls that may be encountered during the interpretative process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16700697     DOI: 10.1111/j.1469-0691.2006.01444.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  45 in total

1.  Preventive behavior for toxoplasmosis in pregnant adolescents in the state of Ceara, Brazil.

Authors:  Fabianne Ferreira Costa; Ana Paula Soares Gondim; Mary Braga de Lima; Jose Ueleres Braga; Luiza Jane Eyre de Souza Vieira; Maria Alix Leite Araújo
Journal:  BMC Public Health       Date:  2012-01-24       Impact factor: 3.295

2.  Adverse fetal outcome in the absence of timely prenatal diagnosis of congenital toxoplasmosis.

Authors:  Tijana Zivković; Vladimir Ivović; Marija Vujanić; Ivana Klun; Branko Bobić; Aleksandra Nikolić; Olgica Djurković-Djaković
Journal:  Wien Klin Wochenschr       Date:  2011-10-20       Impact factor: 1.704

3.  Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.

Authors:  Arnaud Maudry; Gautier Chene; Rémi Chatelain; Hugues Patural; Bahrie Bellete; Bernard Tisseur; Jamal Hafid; Hélène Raberin; Sophie Beretta; Roger Tran Manh Sung; Georges Belot; Pierre Flori
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

Review 4.  Parasitic infections and myositis.

Authors:  Samar N El-Beshbishi; Nairmen N Ahmed; Samar H Mostafa; Goman A El-Ganainy
Journal:  Parasitol Res       Date:  2011-09-01       Impact factor: 2.289

5.  Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women.

Authors:  C Jost; F Touafek; A Fekkar; R Courtin; M Ribeiro; D Mazier; L Paris
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

6.  Evaluation of a New Immunochromatography Technology Test (LDBio Diagnostics) To Detect Toxoplasma IgG and IgM: Comparison with the Routine Architect Technique.

Authors:  Caroline Mahinc; Pierre Flori; Edouard Delaunay; Cécile Guillerme; Sana Charaoui; Hélène Raberin; Jamal Hafid; Coralie L'Ollivier
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

7.  Reverse enzyme-linked immunosorbent assay using monoclonal antibodies against SAG1-related sequence, SAG2A, and p97 antigens from Toxoplasma gondii to detect specific immunoglobulin G (IgG), IgM, and IgA antibodies in human sera.

Authors:  Fernando R Carvalho; Deise A O Silva; Jair P Cunha-Júnior; Maria A Souza; Taísa C Oliveira; Samantha R Béla; Gabriele G Faria; Carolina S Lopes; José R Mineo
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

8.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

9.  Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Authors:  H Fricker-Hidalgo; B Cimon; C Chemla; M L Darde; L Delhaes; C L'ollivier; N Godineau; S Houze; L Paris; D Quinio; F Robert-Gangneux; O Villard; I Villena; E Candolfi; H Pelloux
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

10.  A Quick and Parallel Analytical Method Based on Quantum Dots Labeling for ToRCH-Related Antibodies.

Authors:  Hao Yang; Qing Guo; Rong He; Ding Li; Xueqing Zhang; Chenchen Bao; Hengyao Hu; Daxiang Cui
Journal:  Nanoscale Res Lett       Date:  2009-09-03       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.